search icon

    Market Snapshot

    • S&P Futures

      3,819

    • Dow Futures

      30,822

    • Nasdaq Futures

      11,785

    blog search icon

    Akouos, Inc.

    (NASDAQ:AKUS)

    $3.3

    $-0.16

    -4.62%

    Akouos, Inc. Chart

    AKUS Stock Price Today

    Akouos, Inc. (AKUS) stock declined over -4.62% intraday to trade at $3.30 a share on NASDAQ. The stock opened with a gain of 8.20% at $3.47 and touched an intraday high of $3.59, falling -4.62% against the last close of $3.46. The stock went to a low of $3.21 during the session.

    Stock Snapshot

    $3.46

    Prev. Close

    172.33 Million

    Market Cap

    $3.21

    Day Low

    $3.47

    Open

    34.53 Million

    Number of Shares

    $3.59

    Day High

    -

    P/E ratio

    -2.83

    EPS (TTM)

    6.72

    Cash Flow per Share

    8.89

    Free Float in %

    7.43

    Book Value

    181,768

    Volume

    Akouos, Inc. Historical Data

    DateOpenHighLowCloseVolume
    2022-07-06$3.47$3.59$3.21$3.3181,646
    2022-07-05$3.05$3.75$3.05$3.46275,400
    2022-07-01$4.61$4.81$2.91$3.11976,000
    2022-06-30$5.03$5.13$4.32$4.69404,800
    2022-06-29$4.79$7.15$4.75$5.211,139,600
    2022-06-28$4.45$4.98$4.25$4.89156,000
    2022-06-27$3.9$4.56$3.67$4.44112,600
    2022-06-24$4.29$4.95$3.69$3.973,210,000
    2022-06-23$3.75$4.22$3.71$4.21132,800
    2022-06-22$3.52$4.05$3.425$3.75143,900

    Contact Details

    645 Summer Street
    Suite 200
    Boston, MA 02210
    United States

    Webiste:AKUS

    857 410 1818

    Company Information

    Employees-

    Beta-

    Sales or Revenue0

    5Y Sales Change-

    Fiscal Year Ends2021-12-30

    SectorHealth Care

    IndustryBiotechnology

    About Company

    Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. The company is also developing AK-CLRN1 for the auditory manifestations of Usher syndrome 3A, or USH3A; and AK-antiVEGF for vestibular schwannoma. In addition, its precision genetic medicine platform addresses hearing loss related to genes needed for supporting cell function. The company was incorporated in 2016 and is based in Boston, Massachusetts.

    Frequently Asked Questions

    icon

    What is the current Akouos, Inc. (AKUS) stock price?

    Akouos, Inc. (NASDAQ: AKUS) stock price is $3.3 as of the last check on Wednesday, July 6. During the trading session, AKUS stock reached the peak price of $3.59 while $3.21 was the lowest point it dropped to.

    icon

    AKUS's industry and sector of operation?

    The NASDAQ listed AKUS is part of Biotechnology industry that operates in the broader Health Care sector. Akouos, Inc. , a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals.

    icon

    Who are the executives of AKUS?

    Dr. Emmanuel Simons M.B.A., Ph.D.
    Co- Founder, Pres, CEO & Director
    Ms. Sachiyo Minegishi
    CFO, Treasurer, Assistant Sec. & Principal Accounting Officer
    Ms. Jennifer Anne Wellman M.S.
    Chief Operating Officer
    Dr. Michael John McKenna M.D.
    Co-Founder, Chief Medical Officer & Member of Scientific Advisory Board

    icon

    What is the AKUS stock price today?

    AKUS stock traded closed the last session at $3.3, which is $-0.16 or -4.62% lower than its previous close of $3.46. AKUS's current trading price is 42.55% lower than its 52-week high of $13.69 where as its distance from 52-week low of 2.32% is -75.89%.

    icon

    How many employees does AKUS have?

    Number of AKUS employees currently stands at -. AKUS operates from 645 Summer Street, Suite 200, Boston, MA 02210, United States.

    icon

    Link for AKUS official website?

    Official Webiste of $AKUS is: https://www.akouos.com

    icon

    How do I contact AKUS?

    AKUS could be contacted at AKUS operates from 645 Summer Street, Suite 200, Boston, MA 02210, United States, or at phone #857 410 1818 and can also be accessed through its website.

    icon

    How many shares of AKUS are traded daily?

    AKUS stock volume for the day was 181,768 shares while in the previous session number of AKUS shares traded was 181,646 . The average number of AKUS shares traded daily for last 3 months was 403.29 Thousands.

    icon

    How much did AKUS change today?

    The percentage change in AKUS stock occurred in the recent session was -4.62% while the dollar amount for the price change in AKUS stock was $-0.16.

    icon

    What price range AKUS stock been trading in?

    In the recent session, the day high for AKUS stock was $3.59 while the low for AKUS stock touched on the day was $3.21.

    icon

    What is the market cap of AKUS currently?

    The market value of AKUS currently stands at 172.33 Million with its latest stock price at $3.3 and 34.53 Million of its shares outstanding.